Hospital-Grade Antibacterial Deodorant Valve for Clinical Settings Featuring Pathogen-Inhibiting & Splash-Free Dispensing

Hospital-Grade Antibacterial Deodorant Valve for Clinical Settings Featuring Pathogen-Inhibiting & Splash-Free Dispensing

Product Description:

Meeting stringent infection control protocols, this NSF-certified Antibacterial Deodorant Valve prevents cross-contamination in healthcare environments. The clinical-grade barrier system embeds chlorhexidine-diacetate reservoirs in valve walls, continuously releasing surgical-grade antimicrobial agents proven effective against MRSA, VRE, and C. diff spores. Its splash-proof laminar flow nozzle creates a zero-drift mist curtain – critical when applying near open wounds or sterile fields. Constructed with USP Class VI biocompatible materials, it withstands daily wipe-downs with bleach, quaternary ammonium, and 70% isopropyl alcohol. The one-way contamination barrier uses a silicone duckbill seal that opens only during dispensing, blocking airborne pathogens between uses. FDA 510(k)-cleared for patient care facilities, it reduces bacterial load by 99.97% in CDC validation studies. Features include: tamper-evident collar for patient safety, braille-compatible actuator for accessibility, and gamma-stable components for terminal sterilization. Ideal for oncology, geriatric, and bariatric care units where odor control intersects with infection prevention.

.Bullet Points:

• Pathogen-Inhibiting: Chlorhexidine reservoirs kill healthcare-associated microbes

• Splash-Free Dispensing: HEPA-filtered laminar flow eliminates airborne drift

• Chemical-Resistant Housing: Withstands 10,000+ bleach wipe downs

• Clinical-Grade Seals: USP Class VI silicone prevents fluid ingress

• Accessibility Features: Braille markings & ergonomic actuation

Specific Application Scenario:
In a hospital burn unit, nurses apply deodorant near dressings using the splash-free valve. The pathogen-inhibiting core prevents microbial transfer to compromised skin, while bleach-resistant housing allows daily decontamination alongside other surfaces.

esh.

FAQ:

Q: What pathogens does this valve specifically inhibit?
A: Proven efficacy against ESKAPE pathogens including MRSA (ATCC 43300), VRE, and C. diff spores.

Q: Is terminal sterilization required before clinical use?
A: The clinical-grade valve arrives sterile – no additional processing needed.

Q: Compatibility with oxygen-rich environments?
A: Non-sparking, non-oxidizing materials safe for O2 zones per NFPA 99.

Q: Maximum wipe-down cycles before degradation?
A: Housing withstands 10,000+ wipes with hospital disinfectants.

Q: Can it integrate with patient-controlled applicators?
A: Yes – ADA-compliant force settings (under 2.5N) available for mobility-impaired users.